Cargando…
Characterizing Immune Checkpoint Inhibitor-Induced Hypophysitis and Obstacles in Diagnosis
Background: Immune checkpoint inhibitors (ICI) are used in the treatment of multiple cancers. ICI-induced endocrinopathies are known side effects of many of these agents due to their immunogenic properties. The primary aim of this single institution analysis was to characterize the population who de...
Autores principales: | Johnson, Jake, Abdallah, Dua’A, Kotwal, Anupam, Ganti, Apar Kishor, Goldner, Whitney Sears |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090556/ http://dx.doi.org/10.1210/jendso/bvab048.1273 |
Ejemplares similares
-
OR32-02 Immune Checkpoint Inhibitor-Induced Hypophysitis Is Associated with Improved Overall Survival in Cancer Patients
por: Kotwal, Anupam, et al.
Publicado: (2020) -
SUN-298 Spectrum of Imaging in Immune Checkpoint Inhibitor Induced Hypophysitis
por: Quandt, Zoe, et al.
Publicado: (2020) -
LBODP071 Early Detection Of Immune-mediated Hypophysitis With Use Of Checkpoint Inhibitor Immunotherapy
por: Lai, William, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor-Induced Hypophysitis in Renal Cell Carcinoma: Two Contrasting Case Presentations
por: Okigbo, Chinelo, et al.
Publicado: (2021) -
Stuck at the Checkpoint: Pembrolizumab Induced Hypophysitis With ‘Normal’ Cosyntropin Response
por: Kasiri, Elnaz, et al.
Publicado: (2021)